Laurus Labs Ltd
NSE:LAURUSLABS

Watchlist Manager
Laurus Labs Ltd Logo
Laurus Labs Ltd
NSE:LAURUSLABS
Watchlist
Price: 512.6 INR 4.79% Market Closed
Market Cap: 276.4B INR
Have any thoughts about
Laurus Labs Ltd?
Write Note

Intrinsic Value

The intrinsic value of one LAURUSLABS stock under the Base Case scenario is 377.2 INR. Compared to the current market price of 512.6 INR, Laurus Labs Ltd is Overvalued by 26%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

LAURUSLABS Intrinsic Value
377.2 INR
Overvaluation 26%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
Laurus Labs Ltd

Backtest Intrinsic Value
Dive into the past to invest in the future

Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start backtest now and learn if your stock is truly undervalued or overvalued!

Run Backtest
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Backtest Unavailable

The backtest for LAURUSLABS cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.

Backtest In Progress...
Backtest In Progress...
How do you feel about LAURUSLABS?
Bearish
Neutral
Bullish

Fundamental Analysis

Economic Moat
Laurus Labs Ltd

Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Investment Journal
AI Assistant
AI Assistant
Ask me anything about Laurus Labs Ltd

Provide an overview of the primary business activities
of Laurus Labs Ltd.

What unique competitive advantages
does Laurus Labs Ltd hold over its rivals?

What risks and challenges
does Laurus Labs Ltd face in the near future?

Has there been any significant insider trading activity
in Laurus Labs Ltd recently?

Summarize the latest earnings call
of Laurus Labs Ltd.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Laurus Labs Ltd.

Provide P/S
for Laurus Labs Ltd.

Provide P/E
for Laurus Labs Ltd.

Provide P/OCF
for Laurus Labs Ltd.

Provide P/FCFE
for Laurus Labs Ltd.

Provide P/B
for Laurus Labs Ltd.

Provide EV/S
for Laurus Labs Ltd.

Provide EV/GP
for Laurus Labs Ltd.

Provide EV/EBITDA
for Laurus Labs Ltd.

Provide EV/EBIT
for Laurus Labs Ltd.

Provide EV/OCF
for Laurus Labs Ltd.

Provide EV/FCFF
for Laurus Labs Ltd.

Provide EV/IC
for Laurus Labs Ltd.

Show me price targets
for Laurus Labs Ltd made by professional analysts.

What are the Revenue projections
for Laurus Labs Ltd?

How accurate were the past Revenue estimates
for Laurus Labs Ltd?

What are the Net Income projections
for Laurus Labs Ltd?

How accurate were the past Net Income estimates
for Laurus Labs Ltd?

What are the EPS projections
for Laurus Labs Ltd?

How accurate were the past EPS estimates
for Laurus Labs Ltd?

What are the EBIT projections
for Laurus Labs Ltd?

How accurate were the past EBIT estimates
for Laurus Labs Ltd?

Compare the revenue forecasts
for Laurus Labs Ltd with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Laurus Labs Ltd and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Laurus Labs Ltd against its competitors.

Analyze the profit margins
(gross, operating, and net) of Laurus Labs Ltd compared to its peers.

Compare the P/E ratios
of Laurus Labs Ltd against its peers.

Discuss the investment returns and shareholder value creation
comparing Laurus Labs Ltd with its peers.

Analyze the financial leverage
of Laurus Labs Ltd compared to its main competitors.

Show all profitability ratios
for Laurus Labs Ltd.

Provide ROE
for Laurus Labs Ltd.

Provide ROA
for Laurus Labs Ltd.

Provide ROIC
for Laurus Labs Ltd.

Provide ROCE
for Laurus Labs Ltd.

Provide Gross Margin
for Laurus Labs Ltd.

Provide Operating Margin
for Laurus Labs Ltd.

Provide Net Margin
for Laurus Labs Ltd.

Provide FCF Margin
for Laurus Labs Ltd.

Show all solvency ratios
for Laurus Labs Ltd.

Provide D/E Ratio
for Laurus Labs Ltd.

Provide D/A Ratio
for Laurus Labs Ltd.

Provide Interest Coverage Ratio
for Laurus Labs Ltd.

Provide Altman Z-Score Ratio
for Laurus Labs Ltd.

Provide Quick Ratio
for Laurus Labs Ltd.

Provide Current Ratio
for Laurus Labs Ltd.

Provide Cash Ratio
for Laurus Labs Ltd.

What is the historical Revenue growth
over the last 5 years for Laurus Labs Ltd?

What is the historical Net Income growth
over the last 5 years for Laurus Labs Ltd?

What is the current Free Cash Flow
of Laurus Labs Ltd?

Discuss the annual earnings per share (EPS)
trend over the past five years for Laurus Labs Ltd.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Laurus Labs Ltd

Current Assets 38.3B
Cash & Short-Term Investments 115.3m
Receivables 16.6B
Other Current Assets 21.6B
Non-Current Assets 45.5B
Long-Term Investments 1.7B
PP&E 40.5B
Intangibles 2.7B
Other Non-Current Assets 678.5m
Current Liabilities 31.1B
Accounts Payable 10.5B
Other Current Liabilities 20.6B
Non-Current Liabilities 11.6B
Long-Term Debt 8.6B
Other Non-Current Liabilities 3B
Efficiency

Earnings Waterfall
Laurus Labs Ltd

Revenue
50.5B INR
Cost of Revenue
-23.9B INR
Gross Profit
26.7B INR
Operating Expenses
-22.9B INR
Operating Income
3.8B INR
Other Expenses
-2.3B INR
Net Income
1.5B INR

Free Cash Flow Analysis
Laurus Labs Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate
Earnings Calls

Laurus Labs' Q2 FY '25 results reflected stable revenues of INR 1,224 crores, despite a flat growth year-over-year. While the CDMO division saw an 8% growth, this was offset by an 11% dip in generic API sales, particularly in oncology. The company's gross margins remained strong at 55%, while EBITDA margins were subdued at 15%. Looking ahead, Laurus is optimistic about achieving a full-year EBITDA margin of up to 20%, with growth anticipated from project deliveries in H2. New investments in a small molecule R&D center are expected to enhance capabilities and support future demand, affirming their commitment to advancing their offerings in the CDMO sector.

What is Earnings Call?
Fundamental Scores

LAURUSLABS Profitability Score
Profitability Due Diligence

Laurus Labs Ltd's profitability score is 52/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Positive 3-Year Average ROE
Positive Revenue Growth Forecast
Positive Operating Income
52/100
Profitability
Score

Laurus Labs Ltd's profitability score is 52/100. The higher the profitability score, the more profitable the company is.

LAURUSLABS Solvency Score
Solvency Due Diligence

Laurus Labs Ltd's solvency score is 50/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Low D/E
Long-Term Solvency
Short-Term Solvency
50/100
Solvency
Score

Laurus Labs Ltd's solvency score is 50/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

LAURUSLABS Price Targets Summary
Laurus Labs Ltd

Wall Street analysts forecast LAURUSLABS stock price to drop over the next 12 months.

According to Wall Street analysts, the average 1-year price target for LAURUSLABS is 422.19 INR with a low forecast of 303 INR and a high forecast of 556.5 INR.

Lowest
Price Target
303 INR
41% Downside
Average
Price Target
422.19 INR
18% Downside
Highest
Price Target
556.5 INR
9% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for LAURUSLABS?

Click here to dive deeper.

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for LAURUSLABS is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Ownership

LAURUSLABS Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

Profile

Laurus Labs Ltd Logo
Laurus Labs Ltd

Country

India

Industry

Pharmaceuticals

Market Cap

276.3B INR

Dividend Yield

0.16%

Description

Laurus Labs Limited is an India-based pharmaceutical and biotechnology company. The company is headquartered in Hyderabad, Telangana and currently employs 5,131 full-time employees. The company went IPO on 2016-12-19. The firm is a manufacturer of active pharmaceutical ingredients (API) for antiretroviral (ARV), oncology, cardiovascular, antidiabetics, anti-asthma and gastroenterology. The company also develops and manufactures oral solid formulations, which provide contract research and manufacturing services (CRAMS) to other global pharma companies, and produce specialty ingredients for nutraceuticals, dietary supplements and cosmeceuticals. The firm operates through four business units covering a range of therapeutic applications, including Generics API, which is engaged in the development, manufacture and sale of APIs and advanced intermediates; Generics Finished Dosage Form (FDF), which is engaged in the development and manufacture of oral solid formulations; Synthesis, which is a key starting materials, intermediates and APIs for New Chemical Entities (NCEs), and Bio, which is engaged in the recombinant products.

Contact

TELANGANA
Hyderabad
2nd Floor, Serene Chambers,, Road No. 7, Banjara Hills,, Hyderabad 500 034,
+914039804333
www.lauruslabs.com

IPO

2016-12-19

Employees

5 131

Officers

CEO & Whole Time Director
Dr. Satyanarayana Chava M.Sc., Ph.D.
CFO & Whole-Time Director
Mr. Vantaram Venkata Ravi Kumar Dip in Mgmt., DIS, F.C.M.A.
Executive Vice President of Manufacturing & Operations
Mr. B. V. R. K. Suryadevara Srinivasa Rao
Executive Vice President of Human Resources
Mr. Narasimha Rao Chava
Head of Quality & Executive Director
Dr. Lakshmana Rao Venkata Chunduru M.Sc., Ph.D.
Executive Vice President of Manufacturing
Mr. Srinivasa Rao Suryadevara B.Sc, M.Sc.
Show More
Executive Vice President of Finance
Mr. Chagarlamudi Sita Ramaiah
Executive Vice President of Synthesis
Mr. Dammalapati Venkata Lakshmi Narasimha Rao
Executive VP, Head of Synthesis & Ingredients and Executive Director
Mr. Krishna Chaitanya Chava
Executive Vice President of Portfolio Management
Mr. Rajaram Iyer M.B.A.
Show Less

See Also

Discover More
What is the Intrinsic Value of one LAURUSLABS stock?

The intrinsic value of one LAURUSLABS stock under the Base Case scenario is 377.2 INR.

Is LAURUSLABS stock undervalued or overvalued?

Compared to the current market price of 512.6 INR, Laurus Labs Ltd is Overvalued by 26%.

Back to Top